Canada Markets open in 49 mins

Aptose Biosciences Inc. (APS.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
1.0900-0.0400 (-3.54%)
At close: 11:25AM EDT
Full screen
Previous Close1.1300
Open1.1500
Bid1.0900 x N/A
Ask1.1100 x N/A
Day's Range1.0900 - 1.1500
52 Week Range0.9000 - 3.9100
Volume2,050
Avg. Volume15,077
Market Cap96.954M
Beta (5Y Monthly)1.42
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Aptose Reports Results for the Second Quarter 2022

    ─ HM43239 Preliminary Response Rate of 43% Among R/R AML Patients with FLT3 Mutations Who Failed Prior Therapy with FLT3 inhibitors ─ ─ HM43239 Complete Remissions and Safety Across Three Dose Levels and Multiple Genotypic Subpopulations ─ Conference Call and Webcast at 5:00 pm ET Today SAN DIEGO and TORONTO, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing highly differentiated

  • GlobeNewswire

    Aptose to Present at the Canaccord Genuity 42nd Annual Growth Conference

    SAN DIEGO and TORONTO, July 27, 2022 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing highly differentiated oral kinase inhibitors to treat hematologic malignancies, today announced that Dr. William G. Rice, Chairman, President and CEO of Aptose, and Mr. Fletcher Payne, CFO of Aptose, will attend the Canaccord Genuity 42nd Annual Growth Conference, and Dr. Rice will present at the Conference:

  • GlobeNewswire

    Aptose to Report Second Quarter 2022 Financial Results and Hold Conference Call on Tuesday, August 2, 2022

    SAN DIEGO and TORONTO, July 19, 2022 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage precision oncology company developing highly differentiated oral kinase inhibitors to treat hematologic malignancies, will report financial results for the quarter ended June 30, 2022, on Tuesday, August 2, 2022 after the close of the market, and provide a corporate update. Conference Call & Webcast: Date: Tuesday, August 2, 2022Time: 5:00 PM ETAudio Webcast Only: linkParti